| http://www.w3.org/ns/prov#value | - But such trials are not conducted without reference to a number of considerations.Commencing with the patients themselves, these considerations include the evolution of agents from conventional cytotoxics to novel molecular targeted therapies, the need to adapt research protocols, and trial conduct within the context of changing regulatory environments such as new requirements from the European Me
|
